JPS6152151B2 - - Google Patents
Info
- Publication number
- JPS6152151B2 JPS6152151B2 JP7706084A JP7706084A JPS6152151B2 JP S6152151 B2 JPS6152151 B2 JP S6152151B2 JP 7706084 A JP7706084 A JP 7706084A JP 7706084 A JP7706084 A JP 7706084A JP S6152151 B2 JPS6152151 B2 JP S6152151B2
- Authority
- JP
- Japan
- Prior art keywords
- vef
- ferulic acid
- tocopherol
- benzene
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 24
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims description 10
- 229940114124 ferulic acid Drugs 0.000 claims description 10
- 235000001785 ferulic acid Nutrition 0.000 claims description 10
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims description 10
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims description 10
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 5
- 239000011627 DL-alpha-tocopherol Substances 0.000 claims description 4
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229960000984 tocofersolan Drugs 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- 239000000376 reactant Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 229930003799 tocopherol Natural products 0.000 claims description 3
- 239000011732 tocopherol Substances 0.000 claims description 3
- 229960001295 tocopherol Drugs 0.000 claims description 3
- 235000010384 tocopherol Nutrition 0.000 claims description 3
- -1 tocopherol ferulic acid ester Chemical class 0.000 claims description 3
- WASQWSOJHCZDFK-UHFFFAOYSA-N diketene Chemical compound C=C1CC(=O)O1 WASQWSOJHCZDFK-UHFFFAOYSA-N 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000012046 mixed solvent Substances 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 5
- 239000011709 vitamin E Substances 0.000 description 5
- 229940046009 vitamin E Drugs 0.000 description 5
- 235000019165 vitamin E Nutrition 0.000 description 5
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000014593 oils and fats Nutrition 0.000 description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000017657 Menopausal disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 230000002710 gonadal effect Effects 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Pyrane Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7706084A JPS60222476A (ja) | 1984-04-17 | 1984-04-17 | トコフェロ−ル・フェルラ酸エステルの製造法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7706084A JPS60222476A (ja) | 1984-04-17 | 1984-04-17 | トコフェロ−ル・フェルラ酸エステルの製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60222476A JPS60222476A (ja) | 1985-11-07 |
| JPS6152151B2 true JPS6152151B2 (enExample) | 1986-11-12 |
Family
ID=13623246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7706084A Granted JPS60222476A (ja) | 1984-04-17 | 1984-04-17 | トコフェロ−ル・フェルラ酸エステルの製造法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60222476A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002284625A (ja) * | 2001-03-23 | 2002-10-03 | Nippon Hypox Lab Inc | 化粧料 |
-
1984
- 1984-04-17 JP JP7706084A patent/JPS60222476A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60222476A (ja) | 1985-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10981854B2 (en) | Method for purification of 4-hydroxyacetophenone | |
| EP0703954A1 (fr) | Compositions de derives de polyphenols et leur preparation | |
| JP2007259866A (ja) | ホスファチドの製造と使用 | |
| WO2012173217A1 (ja) | ピロロキノリンキノンジナトリウム塩の結晶およびその製造方法 | |
| MC1358A1 (fr) | Dispositif generateur de vapeur pour fond de sondage | |
| FR2643073A1 (fr) | Procede de preparation d'extraits polyphenoliques de type flavane-3-ol purifies et extraits obtenus | |
| WO2009062662A1 (en) | Pharmaceutical and nutraceutical compositions based on menaquinols | |
| JPH05255367A (ja) | カンタリジン誘導体組成物の製造法及びそれを含む抗ウイルス剤 | |
| JPS61143377A (ja) | シリビニン誘導体、その製法及びこれを含有する火傷、肝臓障害及びキノコ毒の治療剤 | |
| JP2015535216A (ja) | ヒマワリからカフェオイルキナ酸に富んだ抽出物を得る方法 | |
| JPS6388159A (ja) | ドコサヘキサエン酸エステルの製造法 | |
| US4025631A (en) | Dihydroquinoline derivatives of antioxidant activity | |
| US4046765A (en) | Dihydroquinoline derivatives of antioxidant activity and a process for the preparation thereof | |
| JPS621396B2 (enExample) | ||
| JPS5940179B2 (ja) | 酸化防止剤 | |
| CA2628304C (en) | Method of refining episesamin | |
| JPS60222476A (ja) | トコフェロ−ル・フェルラ酸エステルの製造法 | |
| LU84429A1 (fr) | A titre de medicaments,certains derives de l'acide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant | |
| US4146728A (en) | Esters of 2-[4-(4-chlorobenzoyl)-phenoxy-2-methyl-propionic acid with bis-(hydroxyalkylthio)-alkanes | |
| CN108892660A (zh) | 一种阿折地平杂质b的制备方法 | |
| JPH02503792A (ja) | 副腎白質ジストロフィーを治療するための医薬組成物 | |
| CH622251A5 (enExample) | ||
| JPH01228917A (ja) | アラゲキクラゲ抽出物 | |
| BE875451A (fr) | Nouveaux medicaments constitues de derives de l'acide p-amino-benzoique | |
| CN118239995A (zh) | 一种阿魏酸葡萄糖偶联物及其制备方法、应用和衍生物 |